Transmucosal delivery system for medical marijuana
PUGE is working to finalize its design patent for a new transmucosal (nasal spray) delivery system for medical marijuana.
Skin patches for the delivery of
PUGE is conducting feasibility studies on
transdermal (skin) patches for the delivery of
Infused beverages for the delivery of medical marijuana.
PUGE is researching naturally occurring terpenes, similar to essential oils, found in the cannabis plant that can be manipulated to create various flavor profiles.
Medicinal Marijuana Applications:
Cancer, Diabetes, HIV/AIDS, Pain Relief, Multiple Sclerosis, Alzheimer's Disease, Asthma, Glaucoma, Brain Cancer, ALS symptoms, Crohn's disease, Insomnia
Who We are
Cannabis Biotech, a wholly owned subsidiary of Puget Technologies ( OTCQB: PUGE ), is forging new frontiers in cannabinoid research and distribution. As the world grows to accept cannabis-based medicines, we are poised to meet the demand.
Our Research is Sound
Our research and development team is pushing the limits to uncover new and exciting possible distribution methods for those seeking natural, cannabis-based medicine.
The greatest opportunities for investors are in emerging industries and technologies BEFORE market saturation. Cannabis Biotech is at the forefront – leading the way.